TG Therapeutics Inc (TGTX)
16.48
-0.94
(-5.40%)
USD |
NASDAQ |
May 17, 16:00
16.48
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Shareholders Equity (Quarterly): 160.11M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 160.11M |
December 31, 2023 | 160.50M |
September 30, 2023 | 164.77M |
June 30, 2023 | 40.45M |
March 31, 2023 | 27.43M |
December 31, 2022 | 58.59M |
September 30, 2022 | 100.48M |
June 30, 2022 | 129.04M |
March 31, 2022 | 170.39M |
December 31, 2021 | 237.15M |
September 30, 2021 | 311.52M |
June 30, 2021 | 383.13M |
March 31, 2021 | 445.28M |
December 31, 2020 | 519.35M |
September 30, 2020 | 170.66M |
June 30, 2020 | 194.23M |
March 31, 2020 | -1.353M |
December 31, 2019 | 38.62M |
September 30, 2019 | -25.79M |
June 30, 2019 | 13.20M |
March 31, 2019 | 19.25M |
December 31, 2018 | 24.04M |
September 30, 2018 | 71.74M |
June 30, 2018 | 101.38M |
March 31, 2018 | 85.23M |
Date | Value |
---|---|
December 31, 2017 | 66.99M |
September 30, 2017 | 79.55M |
June 30, 2017 | 77.98M |
March 31, 2017 | 101.04M |
December 31, 2016 | 35.87M |
September 30, 2016 | 56.75M |
June 30, 2016 | 78.70M |
March 31, 2016 | 89.45M |
December 31, 2015 | 101.57M |
September 30, 2015 | 116.31M |
June 30, 2015 | 112.95M |
March 31, 2015 | 106.23M |
December 31, 2014 | 80.10M |
September 30, 2014 | 67.08M |
June 30, 2014 | 52.10M |
March 31, 2014 | 54.43M |
December 31, 2013 | 40.05M |
September 30, 2013 | 44.64M |
June 30, 2013 | 10.28M |
March 31, 2013 | 14.70M |
December 31, 2012 | 15.55M |
September 30, 2012 | 9.372M |
June 30, 2012 | 11.02M |
March 31, 2012 | 11.74M |
December 31, 2011 | 9.624M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-25.79M
Minimum
Sep 2019
519.35M
Maximum
Dec 2020
164.89M
Average
160.31M
Median
Shareholders Equity (Quarterly) Benchmarks
Amicus Therapeutics Inc | 130.69M |
Geron Corp | 344.87M |
Editas Medicine Inc | 294.40M |
G1 Therapeutics Inc | 27.74M |
Mersana Therapeutics Inc | 27.98M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 373.32M |
Total Liabilities (Quarterly) | 213.21M |
Debt to Equity Ratio | 0.6329 |
Current Ratio | 3.617 |
Net Debt Paydown Yield | -0.26% |